insights from industryBernd GleixnerDivision President AutomationBruker Biopsin News Medical speaks to Bernd Gleixner, Division President Automation at Bruker Biospin, about the future of lab ...
Employee burnout rates in the healthcare sector were exceptionally high even before COVID-19. Burnout has a significant adverse influence on clinicians’ overall well-being, as well as their sense of ...
In this interview, we speak to Mostafa ElSayed, CEO of Automata, about their new, open, integrated lab automation platform Automata LINQ and how it unlocks labs' people, space and potential. Please ...
Increased patient testing and less lab staff to perform manual tasks have created a bottleneck for care Now, automation found in high-volume labs is accessible no matter a lab’s footprint or volume ...
The Global Lab Automation Market is estimated to be valued at USD 12.465 Billion by 2035 at an exponential growth of 7.15% in the next seven years. The increasing amount of laboratory tests performed ...
Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...
How has technology changed the way we conduct research? Lab automation takes many different forms with the purpose of streamlining several aspects of experiments, data collection and data analysis.
The bioindustry has, in its essence, been about translational medicine, and it is strictly the rise of high throughput (and, hence, automation) that has permitted its development. As several ...
As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...
EFLM recognizes Babson Diagnostics for innovations in sample collection and preparation ...
Dublin, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The "Lab Automation Market Industry Trends and Global Forecasts to 2035: Distribution by Stage of Automation, Type of Instrument, Application, End-user and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results